603896.SH
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 13.80
−1.85%Sep 28, 2026, 02:06 UTC
Shouxiangu and other investors jointly established Hangzhou Huarui Cell and Gene Venture Capital Partnership (Limited Partnership), a venture capital firm investing in unlisted companies.
Source:Aug 27, 2026, 09:34 UTC
Shouxiangu announced its first-half 2026 results: revenue of 276 million yuan, down 7.89% year-on-year, and net profit of 36.87 million yuan, down 43.76% year-on-year.